GSK is set to buy Rapt Therapeutics in a $2.2 billion deal. AstraZeneca agreed to a $630 million pact to secure remaining rights to armored CAR-T from AbelZeta. Bristol Myers Squibb signed a deal with ...
The Canadian Press on MSN
Today-History-Feb01
--- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results